Selonsertib (free base)

CHF 108.00
In stock
SYN-1231-M0011 mgCHF 108.00
SYN-1231-M0055 mgCHF 227.00
SYN-1231-M01010 mgCHF 347.00
SYN-1231-M05050 mgCHF 1'065.00
SYN-1231-M100100 mgCHF 1'784.00
 
More Information
Product Details
Synonyms GS-4997 (free base); 5-(4-Cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide
Product Type Chemical
Properties
Formula C24H24FN7O
MW 445.5
CAS 1448428-04-3
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO. Insoluble in water.
Declaration Manufactured by SynKinase.
Other Product Data Target: ASK1 | Kinase Group: Ser⁄Thr Kinases |

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key YIDDLAAKOYYGJG-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice Keep cool and dry.
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS No
Product Specification Sheet
Datasheet Download PDF
Selonsertib, also known as GS-4997, is an orally bioavailable inhibitor of apoptosis signal-regulating kinase 1 (ASK1), with potential anti-inflammatory, antineoplastic and anti-fibrotic activities. GS-4997 targets and binds to the catalytic kinase domain of ASK1 in an ATP-competitive manner. GS-4997 prevents the production of inflammatory cytokines, down-regulates the expression of genes involved in fibrosis, suppresses excessive apoptosis and inhibits cellular proliferation.
Product References
  1. Design of a phase 2 clinical trial of an ASK1 inhibitor, GS-4997, in patients with diabetic kidney disease: J.H. Lin, et al.; Nephron 129, 29 (2015)
  2. A Quantitative Framework to Evaluate Proarrhythmic Risk in a First-in-Human Study to Support Waiver of a Thorough QT Study: C.H. Nelson, et al.; Clin. Pharmacol. Ther. 98, 630 (2015)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.